Study of Anlotinib Combined With Docetaxel in Non-Driver Mutation Non-squamous NSCLC: the Save Study
Clinical trial NCT03646968 · UNKNOWN
Trial details
- NCT number
- NCT03646968
- Sponsor
- Yongchang Zhang
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-08-01
- Primary completion
- 2024-12-31
- Enrollment
- 43
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.